1. Hamza HS, Gaber KR, Raouf WA, Dohain AM, Mohsen GSA, Elfattah ANA, et al. Fetal echocardiography for early detection of conotruncal anomalies in high risk pregnancies: one year follow-up. J Clin Neonatol 2016;5:35.
2. Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol 2004;104:174-185. PMID:
15229018.
3. Özden S, Delikara MN, Avci A, Fiçicioglu C. Intravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term. Int J Gynaecol Obstet 2002;77:109-115. PMID:
12031560.
4. Trussell J, Guthrie K. Choosing a contraceptive: efficacy, safety, and personal considerations. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Stewart FH, Kowal D, editors. Contraceptive technology. 19th revised ed. New York (NY): Ardent Media, Inc.; 2007. p. 19-47.
5. Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update 2007;13:37-52. PMID:
17050523.
6. Walters KM, Simon RA, Woessner KM, Wineinger NE, White AA. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization. Ann Allergy Asthma Immunol 2017;119:71-76. PMID:
28668243.
7. Allen R, O'Brien BM. Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol 2009;2:159-168. PMID:
19826573.
8. Stephenson ML, Wing DA. Misoprostol for induction of labor. Semin Perinatol 2015;39:459-462. PMID:
26601733.
9. Grady K, Johnston T. Maternal collapse, including massive obstetric haemorrhage, amniotic fluid embolism and cardiac arrest. In: MacLennan K, O'Brien K, MacNab WR, editors. Core topics in obstetric anaesthesia. Cambridge: Cambridge University Press; 2015. p. 191.
10. Green L, Knight M, Seeney FM, Hopkinson C, Collins PW, Collis RE, et al. The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study. BJOG 2016;123:2164-2170. PMID:
26694742.
11. Nankali A, Jalilian N, Keshavarzi F, Rezaei R, Rezaei M. Comparison of efficacy and side effects of different administration routes of misoprostol (oral, vaginal, and sublingual) for second-trimester abortion. Int J Pediatr 2017;5:5887-5895.
12. Ercan Ö, Köstü B, Özer A, Serin S, Bakacak M. Misoprostol versus misoprostol and foley catheter combination in 2nd trimester pregnancy terminations. J Matern Fetal Neonatal Med 2016;29:2810-2812. PMID:
26452400.
13. Daskalakis GJ, Mesogitis SA, Papantoniou NE, Moulopoulos GG, Papapanagiotou AA, Antsaklis AJ. Misoprostol for second trimester pregnancy termination in women with prior caesarean section. BJOG 2005;112:97-99.
14. Cuellar Torriente M, Steinberg WJ, Joubert G. Misoprostol use for second-trimester termination of pregnancy among women with one or more previous cesarean deliveries. Int J Gynaecol Obstet 2017;138:23-27. PMID:
28378361.
15. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams obstetrics. 25th ed. New York (NY): McGraw Hill Professional; 2018.
16. Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 2006;108:924-929. PMID:
17012455.
17. World Health Organization. Health worker role in providing safe abortion care and post abortion contraception. Geneva: World Health Organization; 2015.
18. Borgatta L, French A, Vragovic O, Burnhill MS. Early medical abortion with methotrexate and misoprostol: outcomes and satisfaction among women aged 15-21 years. J Pediatr Adolesc Gynecol 2001;14:9-16. PMID:
11358701.
19. Zikopoulos KA, Papanikolaou EG, Kalantaridou SN, Tsanadis GD, Plachouras NI, Dalkalitsis NA, et al. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Hum Reprod 2002;17:3079-3083. PMID:
12456606.
20. Marwah S, Gupta S, Batra NP, Bhasin V, Sarna V, Kaur N. A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (misoprostol) in management of first trimester missed abortion. J Clin Diagn Res 2016;10:QC14-8.
21. Nath J, Jain M, Najam R, Sharma R. To compare the effectiveness and tolerability of misoprostol as a cervical ripening agent in the first trimester abortion through sublingual and vaginal routes of administration. Bangladesh J Obstet Gynaecol 2016;27:63-66.
22. Küçükgöz Güleç U, Urunsak IF, Eser E, Guzel AB, Ozgunen FT, Evruke IC, et al. Misoprostol for midtrimester termination of pregnancy in women with 1 or more prior cesarean deliveries. Int J Gynaecol Obstet 2013;120:85-87. PMID:
23195293.
23. Naguib AH, Morsi HM, Borg TF, Fayed ST, Hemeda HM. Vaginal misoprostol for second-trimester pregnancy termination after one previous cesarean delivery. Int J Gynaecol Obstet 2010;108:48-51. PMID:
19781700.
24. Karaçor T, Yalınkaya A, Görük N, Özler A, Turgut A. Misoprostol-induced termination of secondtrimester pregnancy in women with a history of cesarean section: a retrospective analysis of 56 cases. Ginekol Pol 2013;84.
25. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002;186:470-474. PMID:
11904609.
26. Iftikhar R, Burney WA. Role of misoprostol in inducing abortion in previous cesarean section. J Surg Pak 2009;14:3.